期刊文献+

Evaluation on biocompatibility of biomedical polyurethanes with different hard segment contents 被引量:1

Evaluation on biocompatibility of biomedical polyurethanes with different hard segment contents
原文传递
导出
摘要 In this paper, polyurethane (PU) materials with different contents of hard segment (20%, 25%, 30%) were prepared based on hexamethylene diisocyanate and polycarbonate diols by solution polymerization. The obtained polycarbonate-urethane (PCU) elastomers were characterized by very good hydrophobic property and excellent resistance to hydrolysis. Hemolysis, recalification time and platelet-rich plasma adhesion were used to evaluate the blood compatibility of the materials. L929 cells cultured with leach liquor of these PU membranes were selected to perform the cytotoxicity experiments. The results indicate that the hemolysis rates of PU membranes are all less than 5%, which can meet the requirement of the national standards for biomaterials. However, compared with 20% and 30% groups, the recalification time of the sample containing 25% hard segment is longer, while the number of platelet adhesion is less. Additionally, cells cultured in the leach liquor of PU membranes with 25% hard segment proliferated relatively more thriving, meaning that this proportion of the material has the lowest cytotoxicity. In this paper, polyurethane (PU) materials with different contents of hard segment (20%, 25%, 30%) were prepared based on hexamethylene diisocyanate and polycarbonate diols by solution polymerization. The obtained polycarbonate-urethane (PCU) elastomers were characterized by very good hydrophobic property and excellent resistance to hydrolysis. Hemolysis, recalification time and platelet-rich plasma adhesion were used to evaluate the blood compatibility of the materials. L929 cells cultured with leach liquor of these PU membranes were selected to perform the cytotoxicity experiments. The results indicate that the hemolysis rates of PU membranes are all less than 5%, which can meet the requirement of the national standards for biomaterials. However, compared with 20% and 30% groups, the recalification time of the sample containing 25% hard segment is longer, while the number of platelet adhesion is less. Additionally, cells cultured in the leach liquor of PU membranes with 25% hard segment proliferated relatively more thriving, meaning that this proportion of the material has the lowest cytotoxicity.
出处 《Frontiers of Materials Science》 SCIE CSCD 2015年第4期397-404,共8页 材料学前沿(英文版)
关键词 polyurethane (PU) hydrolytic stability blood compatibility CYTOTOXICITY polyurethane (PU) hydrolytic stability blood compatibility cytotoxicity
  • 相关文献

参考文献20

  • 1Chen L, Han D, Jiang L. On improving blood compatibility: from bioinspired to synthetic design and fabrication of biointerfacial topography at micro/nano scales. Colloids and Surfaces B: Biointerfaces, 2011, 85(1): 2-7.
  • 2Ratner B D. The catastrophe revisited: blood compatibility in the 21st Century. Biomaterials, 2007, 28(34): 5144-5147.
  • 3Gorbet M B, Sefton M V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials, 2004, 25(26): 5681-5703.
  • 4Mao C, Qiu Y, Sang H, et al. Various approaches to modify biomaterial surfaces for improving hemocompatibility. Advances in Colloid and Interface Science, 2004, 110(1-2): 5-17.
  • 5Szycher M, Siciliano A A, Reed A M. Polyurethane elastomers in medicine. In: Dumitriu S, ed. Polymeric Biomaterials. New York: Marcel Dekker, 1994,233-244.
  • 6Simmons A, Hyvarinen J, Odell R A, et al. Long-term in vivo biostability of poly( dimethylsiloxane )/poly(hexamethylene oxide) mixed macrodiol-based polyurethane elastomers. Biomaterials, 2004, 25(20): 4887-4900.
  • 7Baumann H, Richter A, Klemm D, et al. Concepts for preparation of novel regioselective modified cellulose derivatives sulfated, aminated, carboxylated and acetylated for hemocompatible ultra-thing coatings on biomaterials. Macromolecular Chemistry and Physics, 2000, 201(15): 1950-1962.
  • 8Bernacca G M, Gulbransen M J, Wilkinson R, et al. In vitro blood compatibility of surface-modified polyurethanes. Biomaterials, 1998, 19(13): 1151-1165.
  • 9Jo H Y, Jung W K, Kim S K. Purification and characterization of a novel anticoagulant peptide from marine echiuroid worm, Urechis unicinctus. Process Biochemistry, 2008, 43(2): 179-184.
  • 10Laredo J, Xue L, Husak V A, et al. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Journal of Vascular Surgery, 2004, 39(5): 1059-1065.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部